NCT04103801

Brief Summary

Immunization is one of the most significant preventive health measures in reducing morbidity and mortality caused by infectious diseases. Studies have shown that Sucrose is recommended to reduce pain associated with vaccination in neonates. The main aim of the study was to determine the effectiveness of sucrose in reducing infant's pain outcomes during immunization among 10-24 month-old infants and toddlers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2018

Completed
11 months until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
Last Updated

September 25, 2019

Status Verified

September 1, 2019

Enrollment Period

5 months

First QC Date

October 17, 2018

Last Update Submit

September 24, 2019

Conditions

Keywords

Sucrose,Substance P,Pain,Immunization.

Outcome Measures

Primary Outcomes (1)

  • MBPS

    Modified Behavioral Pain Scale (MBPS) is a validated procedural uni-dimensional pain measurement tool that used to measure behavioral pain outcomes.

    Change MBPS score from the start of injection and up to 3 minutes after immunization

Secondary Outcomes (1)

  • Substance P (SP)

    Change SP level from the start of injection and up to 3 minutes after immunization

Other Outcomes (1)

  • Total crying time

    From start of injection and up to 3 minutes after the immunization

Study Arms (2)

Sucrose group

EXPERIMENTAL

This group received the 2 ml of sweet solution (sucrose)

Dietary Supplement: Sucrose

Water group

PLACEBO COMPARATOR

This group received the 2 ml of water

Dietary Supplement: Sucrose

Interventions

SucroseDIETARY_SUPPLEMENT

Participants in the intervention group were given 2 ml dose of 50% sucrose solution and participants in the placebo group were given 2 ml dose of sterile water. Both groups were administered slowly over 30 seconds sublingually via needle-less syringe immediately prior to the immunization injections.

Also known as: Sweet solution
Sucrose groupWater group

Eligibility Criteria

Age10 Months - 18 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • All healthy children who were attending immunization clinic to have their 10-24 month immunization were invited to this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternal and child health centers

Irbid, 21110, Jordan

Location

MeSH Terms

Conditions

Acute PainPain

Interventions

Sucrose

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DisaccharidesOligosaccharidesPolysaccharidesCarbohydratesSugars

Study Officials

  • Manal K, PhD

    Jordan Uinversity of Sceince and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2018

First Posted

September 25, 2019

Study Start

July 14, 2017

Primary Completion

December 20, 2017

Study Completion

April 3, 2018

Last Updated

September 25, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

The data is confidential and could not be shared.

Locations